8102
-
Core Evidence
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Core Evidence
(309,002) Views
Editor in Chief Gulshan Sharma, MD
1555-175X
ReviewMethylnaltrexone: the evidence for its use in the management of opioid-induced constipation
Peter Deibert, Carola Xander, Hubert E Blum, et al
Core Evidence 2009, 4:247-258
11 December 2009
Review
Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy
Paul Richardson, Constantine Mitsiades, Jacob Laubach, et al
Core Evidence 2009, 4:215-245
17 November 2009
Review
Nilotinib for the treatment of chronic myeloid leukemia: An evidence-based review
Elias Jabbour, Jorge Cortes, Hagop Kantarjian
Core Evidence 2009, 4:207-213
05 October 2009
Review
Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis
Stephen T Sonis
Core Evidence 2009, 4:199-205
24 August 2009
Review
Trabectedin: the evidence for its place in therapy in the treatment of soft tissue sarcoma
Katherine A Thornton
Core Evidence 2009, 4:191-198
21 August 2009
Review
Tocilizumab: The evidence for its place in the treatment of juvenile idiopathic arthritis
Troels Herlin
Core Evidence 2009, 4:181-189
07 August 2009
Review
Agomelatine: The evidence for its place in the treatment of depression
Daniela Eser, Thomas C Baghai, Hans-Jürgen Möller
Core Evidence 2009, 4:171-179
05 August 2009
Review
Golimumab: A novel human anti-TNF-α monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis
Jonathan Kay, Mahboob U Rahman
Core Evidence 2009, 4:159-170
23 July 2009
Review
Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection
Hans-Jürgen Stellbrink
Core Evidence 2009, 4:149-158
22 July 2009
Review
Raltegravir: The evidence of its therapeutic value in HIV-1 infection
Kavya Ramkumar, Nouri Neamati
Core Evidence 2009, 4:131-147
02 July 2009
Review
Lasofoxifene: Evidence of its therapeutic value in osteoporosis
Luigi Gennari, Daniela Merlotti, Vincenzo De Paola, Ranuccio Nuti
Core Evidence 2009, 4:113-129
01 July 2009
Review
Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas
Ayman I Omar, Warren P Mason
Core Evidence 2009, 4:93-111
26 June 2009
Review
Conivaptan: Evidence supporting its therapeutic use in hyponatremia
Melissa Li-Ng, Joseph G Verbalis
Core Evidence 2009, 4:83-92
25 June 2009
Review
Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy
Daniel Z Lieberman, Suena H Massey
Core Evidence 2009, 4:67-82
25 June 2009
Review
Eptifibatide: The evidence for its role in the management of acute coronary syndromes
Ibrahim Shah, Shakeel O Khan, Surender Malhotra, Tim Fischell
Core Evidence 2009, 4:49-65
18 June 2009
Review
Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer
Hari A Deshpande, Scott Gettinger, Julie Ann Sosa
Core Evidence 2009, 4:43-48
10 June 2009
Review
Indacaterol: a new once daily long-acting beta2 adrenoceptor agonist
Kai M Beeh, Jutta Beier
Core Evidence 2009, 4:37-41
18 June 2009
Review
Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout
Angelo L Gaffo, Kenneth G Saag
Core Evidence 2009, 4:25-36
23 June 2009
Review
Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect
E Michael Lewiecki
Core Evidence 2009, 4:13-23
18 June 2009
Review
Exforge® (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact
Jean-Marie Krzesinski, Eric P Cohen
Core Evidence 2009, 4:1-11
17 June 2009
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
